These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6296008)

  • 1. A randomized clinical trial of ceftizoxime and cefamandole in the treatment of serious lower respiratory tract infections.
    Rodriguez J; Vazquez GJ; Bermudez RH; Luina A; Ronda CH
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():209-13. PubMed ID: 6296008
    [No Abstract]   [Full Text] [Related]  

  • 2. Ceftizoxime compared with cefamandole for treatment of soft tissue infections.
    Mills J; Slutkin G; Klein D; Schecter W
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():273-9. PubMed ID: 6296020
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative study of ceftizoxime and cefamandole in the treatment of bronchopulmonary infections.
    LeFrock JL; Molavi A; Lentnek AL; Rolston KV; Chandrasekar PH; Smith BR; Kannangara W; Schell RF; Oaks SS; Carr BB
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():215-21. PubMed ID: 6296009
    [No Abstract]   [Full Text] [Related]  

  • 4. A double-blind evaluation of ceftizoxime versus cefamandole therapy for urinary tract infections.
    Penn RL
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():241-5. PubMed ID: 6296014
    [No Abstract]   [Full Text] [Related]  

  • 5. Ceftizoxime and cefamandole in adult patients with acute respiratory failure.
    Lyons RW; Brock SM; Lahiri B
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():227-8. PubMed ID: 6296011
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative trial of ceftizoxime versus cefamandole in the treatment of acute urinary tract infections.
    Lea AS; Sudan AW; Gould PL; Gentry LO
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():261-3. PubMed ID: 6296018
    [No Abstract]   [Full Text] [Related]  

  • 7. Ceftizoxime therapy of infections in hospitalized patients and comparison with cefamandole for urinary tract infections.
    Cohen E; Mogabgab WJ
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():253-60. PubMed ID: 6296017
    [No Abstract]   [Full Text] [Related]  

  • 8. Ceftizoxime in the treatment of urinary tract infections.
    Plimpton HW; Crawford ED
    J Urol; 1982 Dec; 128(6):1231-2. PubMed ID: 6296465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of cefotiam and cefamandole in respiratory tract infections.
    Beumer HM; Olislagers WP; Kahn M; van Hamersveld JD
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):105-8. PubMed ID: 3886564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary of comparative clinical studies of ceftizoxime and cefamandole, cefazolin and tobramycin.
    Duma RJ
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():303-9. PubMed ID: 6296025
    [No Abstract]   [Full Text] [Related]  

  • 11. Single-blind controlled study of ceftizoxime and cefamandole in the treatment of community-acquired pneumonia.
    Grieco MM; Lange M; Daniels JA; Den M; Amaram N; Kornfeld H
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():223-5. PubMed ID: 6296010
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized controlled study comparing ceftizoxime, cefamandole, and cefoxitin in obstetric and gynaecological surgery: a preliminary report.
    Gordon SF; Russell J
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():289-92. PubMed ID: 6296022
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized clinical trial comparing the safety and efficacy of cefonicid and cefamandole in the treatment of patients with respiratory tract infections caused by susceptible pathogens.
    Azanza JR; Honorato J; Rubio A; Cuena R
    Chemioterapia; 1987 Jun; 6(2 Suppl):449-51. PubMed ID: 3334597
    [No Abstract]   [Full Text] [Related]  

  • 14. Cefoperazone versus cefamandole in the treatment of acute bacterial lower respiratory tract infections.
    File TM; Tan JS; Gardner WG; Baird I
    J Antimicrob Chemother; 1983 Jan; 11(1):75-82. PubMed ID: 6219089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftizoxime treatment of cutaneous and subcutaneous tissue infections.
    Parish LC; Parks DB; Layne PP; Uri JV
    Clin Ther; 1984; 6(5):613-9. PubMed ID: 6090019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefamandole in the treatment of lower respiratory tract infections.
    Clarke CW; Hannant CA; May CS; Rawal BD
    J Antimicrob Chemother; 1980 Nov; 6(6):723-31. PubMed ID: 7440465
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of cefuzonam (CZON) with cefmenoxime in chronic respiratory tract infections by the double-blind method].
    Soejima R; Matsushima T; Niki Y; Kawane H; Kawanishi M; Watanabe M; Hino J; Nakagawa Y; Umeki S; Sumi M
    Kansenshogaku Zasshi; 1986 Aug; 60(8):865-84. PubMed ID: 3098871
    [No Abstract]   [Full Text] [Related]  

  • 18. [Double-blind comparison of cefamandole and cefazolin in the therapy of respiratory tract infections (author's transl)].
    Jpn J Antibiot; 1980 Mar; 33(3):375-409. PubMed ID: 6995640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefamandole in the treatment of purulent respiratory infections. Studies of 3 and 4 g daily in 121 patients.
    Pines A; Jabbar MA; Khorasani MH; Raafat H; Sharma JC
    Chemotherapy; 1981; 27(1):68-72. PubMed ID: 7215006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparative trial with ceftizoxime and cefotaxime in urinary tract infections.
    Tripi M; Pavone-Macaluso M; Giammanco A; Carella G
    Int Urol Nephrol; 1985; 17(3):195-202. PubMed ID: 3910604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.